<DOC>
	<DOCNO>NCT02573701</DOCNO>
	<brief_summary>The purpose study evaluate applicability usefulness guideline treatment diagnosis treatment adolescent schizophrenia , also evaluate compliance treatment accord guideline , compare treatment compliance , severity illness social functioning patient treat accord guideline treatment v patient treatment usual six month follow .</brief_summary>
	<brief_title>Guideline vs Usual Treatment Schizophrenic Adolescents</brief_title>
	<detailed_description>The drug treatment patient Guideline Treatment group follow algorithm , atypical antipsychotic must maintain 6 week evaluation medication change PANSS score show reduction 30 % patient show functional improvement . Clozapine could administer two trial antipsychotic effective . Benzodiazepines , antidepressant , anticholinergic anticonvulsant allow treatment comorbid disorder side effect . The psychosocial treatment include psychoeducation ( three 90 min session family two 45 min session patient ) , follow seven 45 min session train social skill focus verbal non-verbal communication , well conversation skill . Patients also train healthy life style habit include 30 min exercise group . TAU include antipsychotic psychosocial treatment decide clinician</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Total score ≥ 70 Positive Negative Syndrome Scale ( PANSS ) score least 4 ( moderate ) 3 follow core item ( conceptual disorganization , hallucinatory behavior , suspiciousness , unusual thought content ) . Patients require score ≥ 4 symptom Clinical Global Impression Improvement Scale ( CGIS ) Had receive antipsychotic proper doses/ regular antipsychotic treatment least 4 week previous enrollment . Unstable medical condition Their diagnosis change study Had history substance dependence substance use ( except cannabis ) , Females pregnancy Refusal practice contraception study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Treatment</keyword>
	<keyword>Guidelines</keyword>
</DOC>